Understanding the real-time evolution of pathogens and diseases is critical for public health and therapeutic development. iProcess provides end-to-end solutions for global disease surveillance, enabling you to monitor viral and bacterial evolution, track antimicrobial resistance (AMR), and gather critical real-world evidence. Our integrated approach combines strategic protocol design, a vast global network of clinical sites, and expert logistical management to deliver reliable, high-quality data for your most demanding research projects.
Samples from various geographical regions and demographic groups enhance the representativeness of your research, providing a more accurate picture of disease trends and public health.
Our broad network allows for targeted collections across numerous disease types, from prevalent health conditions to rare diseases and emerging health threats.
We work closely with you to design and implement tailored collection protocols to match the specific requirements of your disease surveillance study.
All specimens are sourced in compliance with ethical standards and regulatory requirements, ensuring that your research is conducted with the highest integrity.
Our team of experienced project managers ensures seamless coordination and communication throughout the entire process, from study planning to final sample delivery.
At iProcess Global Research, we are committed to supporting global disease surveillance studies with the highest standards of quality, precision, and speed. By leveraging our vast global network and expertise in biospecimen collection, we help ensure that your research can make meaningful strides in understanding and combating disease worldwide.
The Challenge: A leading diagnostic developer needed to rapidly source two distinct cohorts, healthy participants and patients with cancer, during the peak of the COVID-19 pandemic, navigating extreme logistical disruptions.
Our Solution:We leveraged our agile site activation protocols and robust project management to establish and manage collection across multiple sites simultaneously, ensuring safety and compliance while meeting aggressive timelines.
The Challenge: At the height of the public health crisis, an IVD manufacturer required a diverse range of confirmed positive SARS-CoV-2 biospecimens to validate a new diagnostic assay under immense time pressure.
Our Solution: Our team quickly designed and deployed a custom sourcing protocol, activating our global network to procure a variety of sample types (e.g., swabs, saliva, blood) with associated clinical data, showcasing our scientific rigor and agility.
The primary purpose of disease surveillance is to systematically collect, analyze, and interpret health-related data to detect, prevent, and control the spread of diseases. It provides critical information for public health action, policy decisions, and the development of medical countermeasures like vaccines and drugs.
The main types are passive surveillance, where data is routinely reported by healthcare providers, and active surveillance, where an organization, like iProcess, proactively seeks out data and samples through specific collection programs. Our services focus on active surveillance to meet targeted research goals.
We ensure quality through rigorous standardization. This includes using standardized collection kits, providing comprehensive training to all clinical sites, adhering to strict protocol requirements, and maintaining an unbroken cold chain during shipment to preserve biospecimen integrity.
Yes. While challenging, our global network and custom procurement expertise allow us to activate sites and develop protocols specifically designed to identify and source biospecimens from rare disease patient populations for epidemiological research.
